Navigation Links
GERO's Wearable 2.0 Platform to Improve Performance of Activity Trackers

Las Vegas, NV (PRWEB) January 08, 2014

GERO Corporation today announced the launch of a collaborative effort within the Human Locomotome project to gather and analyze the data of 50,000 Fitbit, Jawbone, and Nike Fuelband users to advance early detection of chronic disease. Chronic diseases are the leading source of health care spending in the United States.

"Locomotor activity, measured by wearable accelerometers, has recently emerged as the single source of an unprecedented volume of continuous high-resolution data characterizing the day-to-day, around-the-clock physiological conditions of millions of people," said Vera Kozyr, co-founder of GERO. "We launched the Human Locomotome project together with our scientists to develop technology for early stage diagnostics by analyzing movement activity. We hope to make the information stable, reliable and accessible."

GERO Lab is a proprietary "crowd-research" wearable 2.0 platform used to collect data and involve people and partners in the study. Ultimately, the GERO Lab platform could help existing activity trackers improve product compliance.

GERO Lab will be able to take advantage of the expected growth in the wearable fitness devices market, expected to reach 90 million units globally by 2017, and another 80 million health-related ones, according to leading research firm ABI (Source: February 2012).

GERO recently conducted a study with 3000 Fitbit users, which confirmed the great potential for the GERO platform. Key takeaways of this study include:
Motor activity contains signatures of particular chronic deceases (metabolic, psychiatric, psychological).
Low-resolution trackers (e.g. Fitbit, Jawbone, etc) can also be used with GERO's mathematical model with sufficient tracking time.
GERO already detects particular health conditions with accuracy.

People who want to contribute their data to the 50K research study may sign up at

Some of the chronic diseases that can be detected through locomotor activity include diabetes, hypertension, Alzheimer’s and depression. The company hopes its information will make possibly earlier interventions with an eye toward prevention.

About GERO

Moscow-based GERO was founded to develop a new technology platform using mathematical models to identify potential risks for age-related diseases through analysis of everyday movement. Data is being gathered from existing motion trackers, and as the technology evolves, users will have access to its analysis of their personal data, discovering early indicators of specific metabolic, psychiatric and neurological conditions. Armed with this knowledge, people can make health and lifestyle choices to preserve quality of life.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Vital Connect, Aventyn Launch Wearable Biosensor Platform for Mobile Patient Monitoring
2. Global Wearable Medical Technology Market 2012 - 2016 : Worldwide Industry Latest Market Share, Growth, Size,Trends , Strategy And Forecast Research Report 2016
3. Phronetic Technologies Announces First Prenatal Smart Wearable Technology; StimElation is Poised for Production
4. Wearable Electronics Market to Reach $8.36 Billion by 2018 at a CAGR of 17.7% - New Report by MarketsandMarkets
5. Wearable Electronics & Smart Textiles Technology Expert Interview - New Announcement by MarketsandMarkets
6. Wearable artificial lung to be developed at Pitt through $3.4 million grant
7. Klingg, the Wearable Magnetic Earphone Cord Holder is Released by Mokao Design
8. Wearable cameras provide new insight into lifestyle behaviors and health
9. 2014 Mint Green Bridesmaid Dresses From Good Platform
10. RURO Announces a New Version of its LIMS platform Limfinity™ - Version 4.2
11. USAFact’s New RapidFACT Screening Platform Will Launch with Multiple Website Facelifts Tied to Both Old and New Products
Post Your Comments:
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
(Date:6/23/2016)... announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... ... ... Astellas is a pharmaceutical ...
Breaking Medicine Technology: